Market Place
Sourcing Support
All News #Library
Others
Bulgarian Academy Reports On IPF As Immunomodulator
18 Sep 2024 //
ACCESSWIRE
Department Of Immunology And Enzolytics Execute Three-Year Deal
09 Sep 2024 //
ACCESSWIRE
Enzolytics And Bulgarian Academy Partner On Immunology Research
31 Jul 2024 //
ACCESSWIRE
Enzolytics Enters Exclusive License For Patented Immunotherapy Cancer Treatment
01 Jul 2024 //
ACCESSWIRE
Enzolytics To Invest In Room Temperature SPAD With Sagaliam
03 Jun 2024 //
ACCESSWIRE
Enzolytics Announces Nitric Oxide Formulation Licensing Intent
22 May 2024 //
ACCESSWIRE
Enzolytics Files Supplemental Information Report on the Sale of Biogenysis and Virogentics to Sagaliam
11 Jul 2023 //
ACCESSWIRE
Enzolytics Offers Update on Virogentics, Inc ITV-1 African Project
26 Jun 2023 //
ACCESSWIRE
Enzolytics Offers Update on Virogentics and Sale Transaction
05 Jun 2023 //
ACCESSWIRE
Enzolytics, Inc. Announces U.S. Distribution of IPF Immune(TM)
13 Dec 2022 //
ACCESSWIRE
Enzolytics, Inc. Announces New Advisory Board Member
24 Oct 2022 //
ACCESSWIRE
Enzolytics Inc. Announces Litigation Success, Accounting Progress
14 Sep 2022 //
ACCESSWIRE
Samsung Biologics partners with Enzolytics Inc for antibody therapies
09 Oct 2021 //
PHARMAFILE
Enzolytics and Samsung Biologics Announce Development & Manufacturing Agreement
07 Oct 2021 //
PRNEWSWIRE
Enzolytics Toward Completion of Clinical Trials for ITV-1 Therapeutic
14 Jun 2021 //
ACESSWIRE
Enzolytics Announces Therapeutic Protocol For Monoclonal Antibodies Production
07 Jun 2021 //
ACCESSWIRE
Enzolytics Reports Progress On Its Multiple Therapeutics Platforms
19 Apr 2021 //
BIOSPACE
Enzolytics Announces the Filing of Updated NIH Grant Applications
22 Mar 2021 //
BIOSPACE
Enzolytics, Inc. Files Provisional Patent for Treatment of Multiple Sclerosis
10 Dec 2020 //
ACCESSWIRE
Enzolytics, Inc. Completes Merger with BioClonetics Immunotherapeutics, Inc.
01 Dec 2020 //
BIOSPACE
Enzolytics, Announces Execution Binding Letter of Intent for Merger BioClonetics
15 Oct 2020 //
BIOSPACE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.